Drugs with anticholinergic properties: a current perspective on use and safety

Cholinergic Central System, Alzheimer's Disease, and Anesthetics Liaison: A Vicious Circle?

(2017) Daniela Schifilliti et al.   JOURNAL OF ALZHEIMERS DISEASE

Risk of first-generation H1-antihistamines: a GA2LEN position paper

(2010) M. K. Church et al.   ALLERGY

Anticholinergic Drugs for the Treatment of COPD Are Safe… Are They?

(2010) Klaus F. Rabe   CHEST

Anticholinergic drug use and risk for dementia: target for dementia prevention

(2010) Frank Jessen et al.   EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE

Trospium chloride has no effect on memory testing and is assay undetectable in the central nervous system of older patients with overactive bladder

(2010) D. Staskin et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

New Antipsychotic Drugs: How Do Their Receptor-Binding Profiles Compare?

(2010) Elliott Richelson   JOURNAL OF CLINICAL PSYCHIATRY

Clozapine and Global Cognition in Schizophrenia

(2010) Tarek K. Rajji et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

TROSPIUM CHLORIDE IS UNDETECTABLE IN THE OLDER HUMAN CENTRAL NERVOUS SYSTEM

(2010) David Staskin et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Use of anticholinergics and the risk of cognitive impairment in an African American population

(2010) N. L. Campbell et al.   NEUROLOGY

Comparison of Available Treatments for Tobacco Addiction

(2010) Aryeh I. Herman et al.   Current Psychiatry Reports

Sensitivity to Antipsychotic Drugs in Older Adults

(2010) Chloe Leon et al.   Current Psychiatry Reports

The Cognitive Cost of Anticholinergic Burden: Decreased Response to Cognitive Training in Schizophrenia

(2009) Sophia Vinogradov et al.   AMERICAN JOURNAL OF PSYCHIATRY

Drugs With Anticholinergic Properties, Cognitive Decline, and Dementia in an Elderly General Population

(2009) Isabelle Carrière et al.   ARCHIVES OF INTERNAL MEDICINE

Modeling cholinergic aspects of schizophrenia: Focus on the antimuscarinic syndrome

(2009) Segev Barak   BEHAVIOURAL BRAIN RESEARCH

A Preliminary Benefit-Risk Assessment of Varenicline in Smoking Cessation

(2009) Kate Cahill et al.   DRUG SAFETY

Rivastigmine in Parkinson's disease dementia

(2009) Shilpa Chitnis et al.   Expert Opinion on Drug Metabolism & Toxicology

Lurasidone: a new drug in development for schizophrenia

(2009) Jonathan M Meyer et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Mecamylamine – a nicotinic acetylcholine receptor antagonist with potential for the treatment of neuropsychiatric disorders

(2009) Ingrid Bacher et al.   EXPERT OPINION ON PHARMACOTHERAPY

Nicotinic acetylcholine receptors: an overview on drug discovery

(2009) Dieter D'hoedt et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Is the inhibition of nicotinic acetylcholine receptors by bupropion involved in its clinical actions?

(2009) Hugo R. Arias   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Anticholinergic Activity of Commonly Prescribed Medications and Neuropsychiatric Adverse Events in Older People

(2009) Prasad S. Nishtala et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Increased Antipsychotic Sensitivity in Elderly Patients

(2009) Hiroyuki Uchida et al.   JOURNAL OF CLINICAL PSYCHIATRY

Flaws in the Serum Anticholinergic Activity Assay: Implications for the Study of Delirium

(2009) Elizabeth A. Cox et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Clinical Pharmacokinetics and Pharmacodynamics of Desloratadine, Fexofenadine and Levocetirizine

(2008) Philippe Devillier et al.   CLINICAL PHARMACOKINETICS

The Effects of Antimuscarinic Treatments in Overactive Bladder: An Update of a Systematic Review and Meta-Analysis

(2008) Christopher R. Chapple et al.   EUROPEAN UROLOGY

Drugs With Anticholinergic Properties as a Risk Factor for Cognitive Impairment in Elderly People

(2008) Iacopo Cancelli et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Anticholinergic Activity of 107 Medications Commonly Used by Older Adults

(2008) Marci L. Chew et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Muscarinic acetylcholine receptors as CNS drug targets

(2007) Christopher J. Langmead et al.   PHARMACOLOGY & THERAPEUTICS